These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26026620)

  • 1. [Quality of registration of dementia diagnosis in primary care: The situation in Spain in 2002-2011].
    de Hoyos-Alonso Mdel C; Bonis J; Bryant V; Castell Alcalá MV; Otero Puime Á
    Aten Primaria; 2016 Jan; 48(1):33-41. PubMed ID: 26026620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumption trends for specific drugs used to treat dementia in the region of Madrid (Spain) from 2002 to 2012.
    de Hoyos-Alonso MC; Tapias-Merino E; Meseguer Barros CM; Sánchez-Martínez M; Otero A
    Neurologia; 2015 Sep; 30(7):416-24. PubMed ID: 24704249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated prevalence of dementia based on analysis of drug databases in the Region of Madrid (Spain).
    de Hoyos-Alonso MC; Bonis J; Tapias-Merino E; Castell MV; Otero A
    Neurologia; 2016; 31(1):1-8. PubMed ID: 25444413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of antipsychotics in patients with dementia in Spain: Comparison with prescription of acetylcholinesterase inhibitors and memantine and analysis of associations].
    Rodríguez Espinosa N; Gonzalez-Colaço Harmand M; Moro Miguel MA
    Rev Esp Geriatr Gerontol; 2024; 59(2):101446. PubMed ID: 38029634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany.
    Hoffmann F; van den Bussche H; Glaeske G; Kaduszkiewicz H
    Int Clin Psychopharmacol; 2010 Jan; 25(1):29-36. PubMed ID: 19934763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prescription of acetylcholinesterase inhibitors and memantine in the Canary Islands, comparison with the Spanish population.].
    Rodríguez-Espinosa N; González-Colaço Harmand M; Miranda Saavedra F; Galván González MÁ; Plasencia Núñez M; Aldea Perona AM; Boada C
    Rev Esp Salud Publica; 2021 Sep; 95():. PubMed ID: 34556625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study.
    Havreng-Théry C; Oquendo B; Zolnowski-Kolp V; Krolak-Salmon P; Bertin-Hugault F; Lafuente-Lafuente C; Belmin J
    Alzheimers Res Ther; 2024 May; 16(1):117. PubMed ID: 38812028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study.
    Beauchet O; Launay CP; Allali G; Watfa G; Gallouj K; Herrmann FR; Annweiler C
    BMC Neurol; 2013 Nov; 13():184. PubMed ID: 24261605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
    Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
    Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
    Raina P; Santaguida P; Ismaila A; Patterson C; Cowan D; Levine M; Booker L; Oremus M
    Ann Intern Med; 2008 Mar; 148(5):379-97. PubMed ID: 18316756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Education and use of dementia drugs: a register-based study of over 600,000 older people.
    Johnell K; Weitoft GR; Fastbom J
    Dement Geriatr Cogn Disord; 2008; 25(1):54-9. PubMed ID: 18037814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cardiovascular safety of dementia medications: a cross-national study.
    Fosbøl EL; Peterson ED; Holm E; Gislason GH; Zhang Y; Curtis LH; Køber L; Iwata I; Torp-Pedersen C; Setoguchi S
    J Am Geriatr Soc; 2012 Dec; 60(12):2283-9. PubMed ID: 23176182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of type 2 diabetes and its duration on incidence rates of dementia death and medication prescription in the Australian population during 2003-2016.
    Mehta K; Magliano DJ; Carstensen B; Salim A; Morton JI; Abimanyi-Ochom J; Anstey KJ; Shaw JE; Sacre JW
    Diabetes Res Clin Pract; 2024 Oct; 216():111795. PubMed ID: 39084293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the prescription of cholinesterase inhibitors and memantine.
    Villar-Fernández I; Bjerrum L; Feja C; Rabanaque MJ
    Dement Geriatr Cogn Disord; 2009; 28(4):373-9. PubMed ID: 19887800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
    Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
    J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews.
    Laver K; Dyer S; Whitehead C; Clemson L; Crotty M
    BMJ Open; 2016 Apr; 6(4):e010767. PubMed ID: 27121704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.